KalVista Pharmaceuticals (KALV) Q2 2023 Earnings

7SepConfirmed
Dec 22
Q4 2022
Q2 2023
Q2 2023
-1.06
-0.95
-0.85
-0.74

Details

Expected EPS
-0.86
Actual EPS
-0.74
Surprise EPS
0.12
Surprise Percent
+13.95%

Description

KalVista Pharmaceuticals (KALV) has reported earnings of -0.74 per share for Q2 2023.

0 Comments

Share your thoughts